Edition:
United States

Basilea Pharmaceutica AG (BPMUF.PK)

BPMUF.PK on OTC Markets Group

92.55USD
--
Change (% chg)

-- (--)
Prev Close
$92.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
131
52-wk High
$92.55
52-wk Low
$62.05

BPMUF.PK

Chart for BPMUF.PK

About

Basilea Pharmaceutica AG is a Switzerland-based company engaged in the research, development and commercialization of pharmaceutical products. The Company focuses on pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology. The Company has a range of drugs to treat drug-resistant... (more)

Overall

Beta: 1.47
Market Cap(Mil.): CHF1,057.68
Shares Outstanding(Mil.): 11.82
Dividend: --
Yield (%): --

Financials

  BPMUF.PK Industry Sector
P/E (TTM): -- 47.98 29.94
EPS (TTM): -5.07 -- --
ROI: -17.54 -2.56 13.01
ROE: -- 5.14 14.16

BRIEF-Basilea Pharmaceutica FY 2016 net loss narrows to CHF 51.3 million

* In 2017, Basilea will further advance clinical development of its oncology drug candidates and expects to complete dose-escalation in bal101553's phase 1/2a studies and bal 3833's phase 1 study

Feb 20 2017

BRIEF-Basilea antifungal Cresemba (isavuconazole) launched in France

* Says basilea's antifungal cresemba (isavuconazole) launched in france Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

Nov 15 2016

More From Around the Web

Earnings vs. Estimates